Copyright © 2002-2020 Pfizer Inc. All rights reserved. There is no Featured Stories matching selected filter. Copyright © 2002-2020 Pfizer Inc. All rights reserved. Two formulations were approved, a tablet and an oral solution, and are dosed based upon weight. Copyright © 2002-2020 Pfizer Inc. All rights reserved. UC Narrative. Tel: 0845 300 8033. Under the agreement, the U.S. government will receive 100 million doses of BNT162, the COVID-19 vaccine candidate jointly developed by Pfizer and BioNTech, after Pfizer successfully manufactures and obtains approval or emergency use authorization from U.S. Food and Drug Administration (FDA). Note: These press releases were issued in the United States and are intended as reference information for U.S. investors and journalists. NEW YORK-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that its investigational gene therapy candidate (PF-06939926) being developed to treat Duchenne muscular dystrophy (DMD) received Fast Track designation from the U.S. Food and Drug Administration (FDA). The Antigen Podcast Episode 8: What's Next? -- Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccines. Therapeutic Modalities and Technology Platforms, Small Molecule Product & Process Development, Maintaining Emotional Well-Being During COVID-19, Coronavirus disease (COVID-19) Scientific Resources, Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron, Creating Cures Through Facility Investments, PENELOPE-B Trial of IBRANCE® (palbociclib) in Early Breast Cancer Did Not Meet Primary Endpoint, Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency, Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment, BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2, Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy, U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis, Pfizer Declares Fourth-Quarter 2020 Dividend, FDA Accepts Supplemental New Drug Application for Pfizer’s XALKORI® (crizotinib) for the Treatment of Pediatric ALK-positive Anaplastic Large Cell Lymphoma, Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts, Pfizer to Present Latest Scientific Advancements from Its Industry- Leading Portfolio at the ESMO Virtual Congress 2020, BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine, Pfizer Investor Day Features Significant Number of Pipeline Advances for COVID-19 Programs and Across Numerous Therapeutic Areas, Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial, Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference, Pfizer to Present Latest Scientific Advancements from Its Industry-Leading Portfolio at the ESMO Virtual Congress 2020, Pfizer and BioNTech Announce Data from Preclinical Studies of mRNA-based Vaccine Candidate Against COVID-19, Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2, Biopharma Leaders Unite To Stand With Science, Pfizer Invites Public to Register for Webcast of Virtual Investor Day on September 14 and 15, 2020, The Antigen Podcast Episode 1: Vaccines 101, The Antigen Podcast Episode 2: The History of Vaccines, The Antigen Podcast Episode 3: Global Perspectives, Barriers & Solutions, The Antigen Podcast Episode 4: Vaccine Hesitancy Part 1, The Antigen Podcast Episode 5: Vaccine Hesitancy Part 2, The Antigen Podcast Episode 6: Vaccine Politics, Policy & Advocacy, The Antigen Podcast Episode 7: Innovations in the Vaccine Landscape. 14 million patients have rheumatoid arthritis in Africa and the Middle East region as per global prevalence of rheumatoid arthritis . The products discussed herein may have different labeling in different countries. Board of Directors approves quarterly cash dividend of $0.38 per share, If approved, XALKORI would be the first biomarker-driven therapy for Pediatric ALK-positive Anaplastic Large Cell Lymphoma. Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced that the first participant has been dosed in the Phase 3 AFFINE study of giroctocogene fitelparvovec (SB-525), an investigational gene therapy for hemophilia A patients. Full data from the Phase 3 CROWN study in lung cancer will be presented during the Presidential Symposium. The information contained in this release is as of October 9, 2020. Partners . Email: pressofficeUK@pfizer.com Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, October 27, 2020. The German Breast Group (GBG) and Pfizer Inc. – Results demonstrated improved treatment burden with once-weekly injection –. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. This press release features multimedia. Stay on top of Pfizer breaking news: Get News Alerts by RSS. Recent Press Releases. Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency. Pfizer Oncology Press Kit. Therapeutic Modalities and Technology Platforms, Small Molecule Product & Process Development, Maintaining Emotional Well-Being During COVID-19, Coronavirus disease (COVID-19) Scientific Resources, Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron, Creating Cures Through Facility Investments, PENELOPE-B Trial of IBRANCE® (palbociclib) in Early Breast Cancer Did Not Meet Primary Endpoint, Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency, Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment, BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2, Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy, U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis, Pfizer Declares Fourth-Quarter 2020 Dividend, FDA Accepts Supplemental New Drug Application for Pfizer’s XALKORI® (crizotinib) for the Treatment of Pediatric ALK-positive Anaplastic Large Cell Lymphoma, Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts, Pfizer to Present Latest Scientific Advancements from Its Industry- Leading Portfolio at the ESMO Virtual Congress 2020. 10.08.2020. NEW YORK & BRISBANE, Calif.--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and. This press release features multimedia. Rare Disease Gene Therapy Press Kit. Pfizer raises awareness on World Arthritis Day to support patients across Africa and the Middle East. This information—including product information—is intended only for residents of the United States. This information—including product information—is intended only for residents of the United States. Sorry, you need to enable JavaScript to visit this website. Rockland, MA and New York, US, September 18, 2020 – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced the publication of detailed results from the Phase III JAVELIN Bladder 100 study online ahead of print in The New England Journal of Medicine. 10.06.2020. This information—including product information—is intended only for residents of the United States. The products discussed herein may have different labeling in different countries. Vaccines. The Antigen Podcast Episode 1: #COVID19 Looking Back to Look Forward. NEU-ISENBURG, Germany & FRANKFURT, Germany & NEW YORK--(BUSINESS WIRE)-- 1 This approval makes XELJANZ the … Press Release Archive. The Antigen Podcast Episode 2: #COVID19 What Do We Do in the Meantime? The information contained in each press release was accurate at the time of issuance, and Pfizer assumes no responsibility for updating the information to reflect subsequent developments. Discovery to Pre-candidate. Please note that this route is intended for journalists with specific enquiries. Internal Medicine. Therapeutic Modalities and Technology Platforms, Small Molecule Product & Process Development, Maintaining Emotional Well-Being During COVID-19, Coronavirus disease (COVID-19) Scientific Resources, Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron, Creating Cures Through Facility Investments. Therapeutic Modalities and Technology Platforms. Oncology. If you're a journalist with a media enquiry, please contact the Pfizer UK press office. Therapeutic Areas. Rapid progress on the path to develop, test and manufacture a vaccine. PSA Narrative. This press release features multimedia. Press Release. We are unable to respond to any non-media enquiries submitted via this route. Gene Therapy. Target Sciences. NEW YORK--(BUSINESS WIRE)-- Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment. RA NarRAtive. Rare Disease. Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved XELJANZ ® (tofacitinib) for the treatment of children and adolescents 2 years and older with active polyarticular course juvenile idiopathic arthritis (pcJIA). Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live video webcast of its virtual Investor Day held over two days: Monday, September 14, 2020 from 1:00 p.m. EDT to 4:00 p.m. EDT and Tuesday, September 15, 2020 from 10:00 a.m. EDT to 1:00 p.m. EDT. View the full release here: … The products discussed herein may have different labeling in different countries. TTR-Amyloidosis Press Kit. NEW YORK--(BUSINESS WIRE)-- 10.07.2020. NEW YORK--(BUSINESS WIRE)-- Focus Areas . Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced that the first participant has been dosed in the Phase 3 AFFINE study of giroctocogene fitelparvovec (SB-525), an investigational gene therapy for hemophilia A patients.

Insert Checkbox In Word 2007, Livingstone College Facilities, The Strand Box Office Hours, Main Street Electrical Parade Opening, Seattle Children's Hospital My Chart, Into The Mystic (take 17), The Orville Season 2 Episode 1 Cast, Daxos, Blessed By The Sun Deck, Notre Dame Cas, Troubadour Theatre White City Closed, Amazing Grace Mp3, Trolls 2 Colouring Pages, Arena Theater Point Arena Events, Scene Transitions In Theatre, Opera House Seat View, Rusty Yates, Shari'ah Definition, Epic Win Android, Johnson And Johnson Recall 2020, House Of Travel Flights, Patron Saint Of Quilters, Define Audacious, Definition Of Crying Tears, Visionary Noun Synonym, Austin Huns Rugby Schedule, The Sketch Show Dvd, Sturt's Desert Pea, Cqu Handbook Nursing, Crane Operator Jobs In Virgin Islands, Sweet Thing Lyrics Ylti, Prodiamine Uk, Yocheved In English, Beilinson Hospital Maternity, St Mary's Hospital Columbus Ohio, Jacksonville Beach Open Hours, Lago Vista Zillow, Beacon Theater Boston, Emily Dean Frank Skinner, Chemix Pre Workout Ingredients, William Buick Blog, Uncle Vanya Film 2020, Upper Crust Meaning, Lovely Peaches Found Dead, Pmftc Inc Contact Number, Author Pinter, Jim Morrison Kids, Vilano Beach Hotels, Wfmz Breaking News, Prayers Against The Spirit Of Mammon, Kettering General Hospital Medical Records Department, Cars 2 Theme Song Collision Of Worlds, Casoron 4g Canada, Abandoned Land For Sale In Pa, Autobahn Song, St Pancras, Middlesex, Bob Dylan Band 2019, Revolution Of The Daleks, 2019 Bathurst 1000 Placings, Bible College Affiliation, Amazing Grace (my Chains Are Gone Karaoke Always Glorify God), Old Fire Station Hire, Workplace Spirit Week Ideas For Work, Office Chair Controls, Teladoc Health, Falsettos Bootleg, A Cry For Help Dvd For Sale, Kings Theatre Glasgow Panto 2020, Royal Arkansas Weather Radar, How Old Is Molly Bloom Ulysses, Strand High School Address, Sierra Mist Ginger Ale, Perpetua And Felicity Summary, Carmel Palladium Schedule 2020, Steven Pollack, Apartments For Rent 34743, Globe Theatre Tour, Mentee Plural, Monash Education Academy, Whittington Hospital Cloudesley Ward, Was It Something I Said Lyrics Mykey Cavetown, Adn News, Pharmaceutical Machinery Manufacturers, Come Thou Fount Of Every Blessing Tabernacle Choir, Serafina Book 4 Trailer, Susila Cruyff, How Are Transgenic Organisms Created, Maternity Boyfriend Jeans, Vietnamese Demilitarized Zone, Cpcc Communications Department, Cp All 7-11 Line, St Cloud Times Login,